Document Detail


The effects of fetal exposure to danazol.
MedLine Citation:
PMID:  1606119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess the consequences of exposure to danazol in utero. Additionally, by assessing the risk, to facilitate the counselling of pregnant women inadvertently exposed to danazol in early pregnancy. DESIGN: Retrospective review of reported case histories. SUBJECTS: 129 women exposed to danazol during pregnancy were identified from individual case reports, data from the Australian Drug Reactions Advisory Committee and the United States Food and Drug Administration and from the reports of danazol exposure made directly to the manufacturers. MAIN OUTCOME MEASURES: Teratogenic effects of fetal exposure to danazol in relation to dosage and duration of exposure. RESULTS: Of the 129 reported pregnancies, 12 miscarried and 23 were aborted. Of the 94 completed pregnancies, 37 resulted in the birth of normal males, 34 in non-virilized females and 23 in virilized females. Virilization occurred in a proportion of female fetuses with a pattern of cliteromegaly, fused labia and urogenital sinus formation. Surgery to the genital tract was usually, but not always, required in childhood. The abnormality has not been reported where danazol therapy had been discontinued before the 8th week of pregnancy. Although more common in the higher dosages, virilization was reported in one case with a 200 mg daily dosage. CONCLUSIONS: Danazol should remain contraindicated in pregnancy and clinicians should give careful contraceptive advice to patients commencing or continuing danazol therapy. Nonetheless it is possible to be cautiously optimistic about the outcome of danazol-exposed pregnancies, particularly if treatment is discontinued before 8 completed weeks gestation.
Authors:
P J Brunskill
Related Documents :
9949339 - Databases in the assessment of the effects of drugs during pregnancy.
15304599 - Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.
9661569 - Tramadol reduces the sweating, vasoconstriction, and shivering thresholds.
12185759 - Epilepsy and pregnancy.
11295409 - Use of antibiotics to treat bacteriuria of pregnancy in the nordic countries. which ant...
18818179 - No association found between use of very large doses of diazepam by 112 pregnant women ...
21962149 - The predictive value of leukocyte parameters for hypertensive disorders of pregnancy in...
22876799 - Early preterm delivery due to placenta previa is an independent risk factor for a subse...
24488879 - Fetal doppler changes as a marker of failure to reach growth potential at term.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of obstetrics and gynaecology     Volume:  99     ISSN:  0306-5456     ISO Abbreviation:  Br J Obstet Gynaecol     Publication Date:  1992 Mar 
Date Detail:
Created Date:  1992-07-23     Completed Date:  1992-07-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7503752     Medline TA:  Br J Obstet Gynaecol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  212-5     Citation Subset:  AIM; IM    
Affiliation:
Airedale General Hospital, Keighley, W. Yorks, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / etiology*
Danazol / adverse effects*
Dose-Response Relationship, Drug
Female
Genitalia, Female / abnormalities*
Hermaphroditism / chemically induced
Humans
Maternal-Fetal Exchange
Pregnancy
Retrospective Studies
Risk Factors
Chemical
Reg. No./Substance:
17230-88-5/Danazol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum and intracellular magnesium during normal pregnancy and in patients with pre-eclampsia.
Next Document:  A tale of two prior probabilities--avoiding the false positive antenatal diagnosis of autosomal rece...